help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This version published online on August 31, 2006
Endocrinology, doi:10.1210/en.2006-0826
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/12/5564    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Funder, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Funder, J. W.

Submitted on June 19, 2006
Accepted on July 13, 2006

ALDOSTERONE AND THE CARDIOVASCULAR SYSTEM: GENOMIC AND NONGENOMIC EFFECTS

John W. Funder*

Prince Henry's Institute of Medical Research, P.O. Box 5152, Clayton, Victoria, Australia 3168

* To whom correspondence should be addressed. E-mail: john.funder{at}princehenrys.org.

There is clear evidence for rapid nongenomic effects of aldosterone in the cardiovascular system, in addition to its well characterized effects of unidirectional transepithelial sodium transport. Many of these effects are mediated by the classical mineralocorticoid receptors, though others may be exerted independently. Given that mineralocorticoid receptors are largely constitutively occupied but not activated by physiologic glucocorticoids, effects of aldosterone administered in vitro or in vivo may or may not equate with true physiologic mineralocorticoid roles. In many systems (e.g. blood pressure regulation, cardiac fibrosis) the time course of effects is such that it is not possible - and perhaps not important - to distinguish between rapid nongenomic and classical genomic effects in the context of homeostatic physiology.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
N. Lopez-Andres, C. Inigo, I. Gallego, J. Diez, and M. A. Fortuno
Aldosterone Induces Cardiotrophin-1 Expression in HL-1 Adult Cardiomyocytes
Endocrinology, October 1, 2008; 149(10): 4970 - 4978.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
D. G. Romero, M. W. Plonczynski, B. L. Welsh, C. E. Gomez-Sanchez, M. Y. Zhou, and E. P. Gomez-Sanchez
Gene expression profile in rat adrenal zona glomerulosa cells stimulated with aldosterone secretagogues
Physiol Genomics, December 19, 2007; 32(1): 117 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. R. Hammes and E. R. Levin
Extranuclear Steroid Receptors: Nature and Actions
Endocr. Rev., December 1, 2007; 28(7): 726 - 741.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. J. Rickard, J. W. Funder, J. Morgan, P. J. Fuller, and M. J. Young
Does Glucocorticoid Receptor Blockade Exacerbate Tissue Damage after Mineralocorticoid/Salt Administration?
Endocrinology, October 1, 2007; 148(10): 4829 - 4835.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society